Sînonîm:

1,3,5-Triazin-2(1H)-one, 4-aMino-1-β-D-ribofuranosyl-;4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin- 2(1H) -yek
Ladakamycin;Azacitidine(5-Azacitidine);Azacitidine(Vidaza);4-aMino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)-1 ,3,5-triazin-2(1H)-one;Azacitidine (150 mg);4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran -2-yl)-1,3,5-triazin-2;4-Amîno-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
Ladakamycin

PÊŞÎNÊN Kanonîkî:C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N

Koda HS:29349990

Density:1.4287 (bi texmînî)

Xala kelandinê:387,12°C (bi texmînî)

Indeksa Refractionê:1.6590 (texmîn)

Xala helandinê:226-232 °C (beran.) (lîn.)

alpha:40o(C=1,H2O22oC)

Embarkirinî:2-8°C

PKA:13.46±0.70 (Pêşbînî kirin)

Xuyabûnî:toza lyophilized

Kodên xetereyê:T

Daxuyaniyên Risk:45-46-22

Daxuyaniyên Ewlekariyê:53-22-36/37/39-45

WGK Almanya:3